Log In
BCIQ
Print this Print this
 

MK-8591

  Manage Alerts
Collapse Summary General Information
Company Merck & Co. Inc.
DescriptionNucleoside reverse transcriptase translocation inhibitor
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase I
Standard IndicationHIV / AIDS
Indication DetailsTreat HIV-1 infection
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today